Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crispr/CAS-related methods and compositions for treating primary open angle glaucoma

Crispr/CAS-related methods and compositions for treating primary open angle glaucoma

US Patent 12460231 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
TAL-Tet1 fusion proteins and methods of use thereof2024
Phenothiazine derivatives and uses thereof2024
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific g2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression2024
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023
Methods and compositions for treating cone-rod retinal dystrophy2023
Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided ge2023
Compositions and methods for treating CEP290 associated disease2023